Risk Factors and Outcomes of Multidrug-Resistant Bacteria Infection in Infected Pancreatic Necrosis Patients
Jiongdi Lu,Yixuan Ding,Yuanxu Qu,Wentong Mei,Yulin Guo,Zhen Fang,Chang Qu,Chongchong Gao,Feng Cao,Fei Li,Yulu Feng
DOI: https://doi.org/10.2147/IDR.S387384
2022-12-03
Infection and Drug Resistance
Abstract:Jiongdi Lu, 1, 2 Yixuan Ding, 1, 2 Yuanxu Qu, 1, 2 Wentong Mei, 1, 2 Yulin Guo, 1, 2 Zhen Fang, 1, 2 Chang Qu, 1, 2 Chongchong Gao, 1, 2 Feng Cao, 1, 2, &ast Fei Li, 1, 2, &ast Yulu Feng 3 1 Clinical Center of Acute Pancreatitis, Capital Medical University, Beijing, People's Republic of China; 2 Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, People's Republic of China; 3 Department of Pediatric, Chui Yang Liu Hospital Affiliated Tsinghua University, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Fei Li; Feng Cao, Clinical Center of Acute Pancreatitis, Capital Medical University, Department of General Surgery, Department of Surgery, Xuanwu Hospital, Capital Medical University, No. 45, Changchun Street, Xicheng District, Beijing, 100053, People's Republic of China, Tel +86-10-83198731, Fax +86-10-83198868, Email ; Objective: The incidence of acute pancreatitis (AP) is increasing. Twenty percent of AP patients with developing necrotizing pancreatitis (NP), while ~40– 70% of NP patients develop potentially fatal infectious complications. When patients are suspected or confirmed infected pancreatic necrosis (IPN), antibiotics should be administered timeously to control the infection, but long-term use of antibiotics can lead to multidrug-resistant bacteria (MDRB) infection and eventually to increased mortality. Our study aimed to determine the incidence of MDRB infection and evaluate the risk factors for MDRB infection in IPN patients. Methods: Clinical data of IPN patients admitted to the general surgery department of Xuanwu Hospital of Capital Medical University between January 1, 2014, and December 31, 2021, were retrospectively analyzed. Results: IPN patients (n = 267) were assigned to MDRB infection (n = 124) and non-MDRB infection (n = 143) groups. On admission, patients in the MDRB group had a higher modified computer tomography severity index (CTSI) score ( P 14 days), pancreatic parenchyma and/or peripancreatic fat tissue necrosis develop, and AP progresses to necrotizing pancreatitis (NP). More patients die due to infected pancreatic necrosis (IPN) caused by complications such as septic shock and death. 1–5 The current guidelines and meta-analysis suggest that prophylactic application of antibiotics does not reduce the risk of infection in AP patients and recommends that antibiotics only for patients with suspected or confirmed infection. 6,7 In addition, in the early stages of AP patients, because of similar clinical symptoms of SIRS and infection (eg, fever, elevated white blood cells, shortness of breath), about 2/3 of patients received at least one course of antibiotic therapy history during their admission. 8,9 In recent years, the decline in production costs of antibiotics, lack of antibiotic management processes in the community and local -Abstract Truncated-
pharmacology & pharmacy,infectious diseases